[The artery and the myocardium, two post-infarction targets].
Aupetit
J-F
JF
Centre Hospitalier Saint-Joseph, Saint-Luc, Lyon, France.
Senac
J-P
JP
Latini
R
R
Zannad
F
F
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy*; D017202:Myocardial Ischemia / Q000209:etiology* / Q000473:pathology; D012307:Risk Factors; D018487:Ventricular Dysfunction, Left
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists